Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Biotin and Potassium are closely matched across evidence, studies, and safety.
Verdict
Probably helps
5 of 8 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
10 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Biotin and Potassium have evidence — compare verdict strength side-by-side.
2500-5000mcg (2.5-5mg) for hair/nails
Any time of day
Biotin capsules or tablets
99-500mg daily from supplements (food provides more)
With food to reduce GI upset, Spread throughout day, During/after exercise for athletes
Potassium Citrate or Potassium Gluconate
3-6 months
3-6 months
2-4 weeks
1-2 weeks
Long-term
With excess or kidney issues
Quantitative comparison of the efficacy of clinical drug treatments for primary progressive multiple sclerosis
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2023) · Meta analysis · n=3779
Among these, ocrelizumab showed outstanding performance, with wCDP% of 72.6 at 96 weeks, while the proportions of rest of the drugs ranged between approximately 55-70%.
Vitamin supplementation in the treatment of optic neuritis: A systematic review and meta-analysis
Multiple sclerosis and related disorders (2025) · Meta analysis · n=2465
The effect of MD1003 (high-dose biotin), vitamin A, and vitamin D on retinal nerve fiber layer (RNFL) thickness from pooled results showed a mean change of 0.15 (SMD 0.15, 95 % CI, -0.33 to 0.64, I2 = 61 %, τ² = 0.11, p = 0.08), which was not significant.
High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials
Multiple sclerosis and related disorders (2021) · Meta analysis · n=830
Pooled data for ITW25 at 12 to 15 months yielded statistical significance (RR 2.06; 95% CI 1.04-4.09; 2 trials; 796 participants; I2 = 0%) [moderate COE] favoring HDB among patients with PMS.
Effect of changes in potassium intake on blood pressure: a dose–response meta-analysis of randomized clinical trials (2000–2024)
Clinical Kidney Journal (2025) · Meta analysis · n=2500
Dose-response analysis of RCTs from 2000-2024
Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Nutrients (2024) · Meta analysis
Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations.
Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies
BMC medicine (2024) · Meta analysis · n=237036
Meta-analysis examining Potassium efficacy
Both Biotin and Potassium are closely matched — the best choice depends on your specific health goals.
No known interactions between Biotin and Potassium have been documented in our database. However, always consult a healthcare provider before combining supplements.